find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
298
Clinical Trials
Phase 1 Clinical Trials
Phase I/II
Accepting Patients
nct/study# NCT04959981 / ERAS-007-02
Phase 1b/2, Open-Label, Multicenter Study Of ERAS-007 In Combination With Other Anti-Cancer Therapies In Patients With Advanced Non-Small-Cell Lung Cancer (HERKULES-2)
Learn More
Phase 1 Clinical Trials
Phase I/II
Accepting Patients
nct/study# NCT04145622 / DS7300-A-J101
Phase I/II, Two-Part, Multicenter First-In-Human Study Of DS-7300a In Subjects With Advanced Solid Malignant Tumors
Learn More
Phase 1 Clinical Trials
Phase I
Accepting Patients
nct/study# NCT04612751 / DS1062-A-U104
A Phase 1b, Multicenter, 2-Part, Open-Label Study Of DS-1062a In Combination With Durvalumab In Subjects With Advanced Or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations And Previously Treated With Platinum-Based Chemotherapy With Or Without Prior Immunotherapy
Learn More
Phase 1 Clinical Trials
Phase I/II
Accepting Patients
nct/study# NCT03997968 / CYT-0851-01-REFMAL-639
A Multi-Center, Open Label Phase 1/2 Study Of CYT-0851, An Oral RAD51 Inhibitor, In Patients With Relapsed/Refractory B-Cell Malignancies And Advanced Solid Tumors
Learn More
Phase 1 Clinical Trials
Phase I/II
Accepting Patients
nct/study# NCT04104776 / 0209-01
A Phase 1/2 Study Of CPI-0209 Monotherapy And In Combination With Other Therapy In Patients With Advanced Tumors
Learn More
Phase 1 Clinical Trials
Phase II
Accepting Patients
nct/study# NCT04083976 / 42756493CAN2002
A Phase 2 Study Of Erdafitinib In Subjects With Advanced Solid Tumors And Selected FGFR Gene Alterations.
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.